Trial | NCT00001127  Report issue

Title

Study of a Flu Vaccine in Children
Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    15000
This study tests the safety and effectiveness of a flu vaccine in school children.

School children are usually the first members of a community to come down with the flu, and they often give the flu to their younger siblings, parents, and grandparents. It is hoped that giving school children a flu vaccine can help prevent the spread of the flu to other members of the community.
This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.
Study Started
Jan 17
2000
Study Completion
Nov 30
2005
Last Update
Aug 27
2010
Estimate

Biological Influenza virus vaccine (CAIV-T)

Criteria 

Inclusion Criteria:

Your child may be eligible for this study if he/she:

Is between the ages of 18 months and 18 years, with consent of parent or guardian.
Is a resident of the Temple-Belton, Texas area.

Exclusion Criteria:

Your child will not be eligible for this study if he/she:

Has had a fever within 3 days before vaccination.
Has symptoms of a weakened immune system.
Has had a wheezing episode within the past 2 weeks.
Has moderate to severe asthma.
Is allergic to eggs.
Needs to take aspirin on a regular basis.
Has received another vaccine or study drug in the past month.
No Results Posted